Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 1,261-1,272 of 23,847
Behavioral study icon
RecruitingISRCTN95575369

Collaborative Care: Depression Initative in the Medical setting

This study is looking at a support or therapy approach for people with Chronic medically ill, Comorbid depression, Mental and Behavioural Disorders, or Depression. Participants take part in the program or support approach and complete follow-up assessments.

In Netherlands
DepressionOther
Countries
Netherlands
Sponsor
Trimbos-institute/Netherlands Institute of Mental Health and Addiction (The Netherlands)
Condition
Depression
Other study type icon
RecruitingISRCTN15266438

Collaborative Care: Depression Initiative in Primary care

This study is looking at whether a digital support tool can help people with Depressive disorders, Mental and Behavioural Disorders, or Depression. Participants take part in a digital support tool and complete follow-up assessments.

In Netherlands
DepressionOther
Countries
Netherlands
Sponsor
Trimbos-institute/Netherlands Institute of Mental Health and Addiction (The Netherlands)
Condition
Depression
Drug study icon
RecruitingNCT04917302

Combination of NMDA-enhancing and Anti-inflammatory Treatments for Schizophrenia

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

In Taichung
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
Taiwan
Sponsor
China Medical University Hospital
Condition
Schizophrenia
Drug study icon
RecruitingNCT04959201

Combination of NMDA-enhancing and Antioxidant Treatments for Schizophrenia

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

In Taichung
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Taiwan
Sponsor
China Medical University Hospital
Condition
Schizophrenia
Drug study icon
RecruitingNCT04422652

Combination of Novel Therapies for CKD Comorbid Depression

This study is comparing Bupropion with placebo for people with Chronic Kidney Diseases, depression, or End Stage Kidney Disease. Participants receive Bupropion or placebo and complete study visits and assessments.

Multiple locations, including Stony Brook
DepressionDrugOver 18 Years
Countries
United States
Sponsor
Stony Brook University
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.